CYP1A1 and colorectal cancer: Likewise, the siRNA-mediated inhibition of β-catenin signaling, aberrantly activated in a majority of colorectal cancers, modulated genotoxicity of dietary carcinogen BaP in colon cell model in vitro, via a mechanism involving up-regulation of CYP1 expression and activity (46).